Felicia F. Norwood - Mar 3, 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & President,Gov Health Ben
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol: ELV
Transactions as of: Mar 3, 2025
Transactions value $: -$1,033,442
Form type: 4
Date filed: 3/5/2025, 04:50 PM
Previous filing: May 2, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	-$1.03M	-2.61K	-9.57%	$395.50	24.7K	Mar 3, 2025	Direct	F1
transaction	ELV	Common Stock	Award	$0	+3.04K	+12.29%	$0.00	27.7K	Mar 3, 2025	Direct	F2
transaction	ELV	Common Stock	Award	$0	+4.21K	+15.2%	$0.00	31.9K	Mar 3, 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+11.5K		$0.00	11.5K	Mar 3, 2025	Common Stock	11.5K	$395.50	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 1,011 shares on 3/3/2026, and 1,012 shares each on 3/3/2027 and 3/3/2028.
F3	Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
F4	The option represents a right to purchase a total of 11,549 shares, and is exercisable in three annual installments, with one installment of 3,849 shares and two installments of 3,850 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.